Bristol-Myers Squibb to invest in Compugen as companies agree to test Opdivo, COM701 combination in advanced solid tumours https://firstwordpharma.com/node/1596651?tsid=28®ion_id=6 …
More From BioPortfolio on "Bristol-Myers Squibb to invest in Compugen as companies agree to test Opdivo, COM701 combination in advanced solid tumours https://firstwordpharma.com/node/1596651?tsid=28®ion_id=6 …"